Agilent gains expanded approval of diagnostic test for potential Keytruda patients

RegulatoryapprovedKeytrudaPositive

AI Analysis

Agilent received expanded approval for a diagnostic test designed to identify potential patients eligible for Merck's Keytruda treatment.

expanded approval of diagnostic test

Importance:6/10

Sentiment:

0.70

diagnosticsregulatory approvalcompanion diagnosticexpansion

Related Companies

Read the original article

Published by Seeking Alpha Healthcare on June 3, 2026 2:47 PM